
Eloi Suinot
Analyst
Valentino, soon to be owned by Kering, hires a sector heavyweight
Kering still owns only 30% of Valentino, but its full acquisition by 2028 has been contractually agreed. Many investors would like to see this contract renegotiated to allow Luca De Meo, the group's future CEO, to focus on his long to-do list.
August 21, 2025 at 10:24 am
Pop Mart and Chinese stuffed animals set out to conquer the world
There is something of Pokémon about Pop Mart's strategy. You open a box without knowing what's inside and collect useless but stylish toys. A true showcase of Chinese soft power, these figurines are all the rage in the West, like few local brands before them. Are we at the beginning of the wave or approaching the decline of yet another shortlived trend?
August 20, 2025 at 12:50 pm
Novo Nordisk: Wegovy - beyond diabetes and obesity
Under pressure from Donald Trump to lower drug prices, Novo Nordisk is halving the price of Ozempic, its diabetes treatment, in the US. In addition, Wegovy has become the only GLP-1-based drug approved in a new market that affects 5% of Americans.
August 19, 2025 at 11:17 am

A stock for those looking for treasures under the sea
For this second edition, we're heading for the deep blue sea. Underwater exploration, still largely unexplored, is at the heart of Kraken Robotics' ambition. Even Mars is better mapped than our oceans, and the Canadian company has decided to tackle the technical challenges of these complex missions. Portrait of a former penny stock that is betting on defense in a sector where innovation is a condition for survival.
August 18, 2025 at 10:41 am
Italy catches up with France on 10-year rates, a first since 2008
Just a month ago, we were talking here about the end of the historic spread on short-term maturities between Italy and France. Now we are back with a slightly more alarming observation: the end of the spread between 10-year bonds. And Giorgia Meloni does not intend to stop there: she is now targeting Germany.
August 15, 2025 at 12:20 pm

The Swiss stockmarket remains unfazed
The Swiss government has returned empty-handed from its impromptu visit to Washington, and tariffs are now in effect. However, the Swiss index is resisting, remaining stable, with the country's growth hardly affected by the situation.
August 12, 2025 at 04:09 pm
Is it back to square one for Eli Lilly?
After a series of setbacks for Novo Nordisk, Eli Lilly had almost lost sight of the Danish group in its rearview mirror. But the tide could be turning. The results of the study on the oral version of its obesity treatment are in, and they are very disappointing.
August 07, 2025 at 06:20 pm
Discover our authors
Chief Editor
Senior Analyst
Journalist
Analyst
Journalist
- Stock Market
- Our authors
- Eloi Suinot

































